Intuitive Expands da Vinci SP Applications in Europe

Intuitive Surgical, a global leader in minimally invasive care, has expanded the applications of its da Vinci SP surgical system in Europe. The company has received CE mark approval for the use of the da Vinci SP system in transvaginal gynecologic procedures, marking a significant milestone for the technology.

This approval, announced on September 14, 2026, broadens the range of procedures the da Vinci SP system can perform in Europe. Currently, the system is approved for endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast surgical procedures. The new indication for transvaginal gynecologic procedures represents a substantial step forward in the system's capabilities and accessibility.

Dirk Barten, Intuitive's commercial president for Europe, emphasized the importance of this approval.

The da Vinci SP system is designed to enable surgeons to perform procedures through a single incision or natural orifice, offering enhanced visualization and precision in narrow or deep anatomical spaces. With the new approval, surgeons can now use the system to perform transvaginal procedures, which can offer several advantages over traditional surgical methods. These include shorter recovery times and a reduced risk of scarring, as the system allows for minimally invasive surgery.

Tilman Schlick, vice president of medical affairs and medical officer at Intuitive in Europe, highlighted the potential benefits of the new indication.

A growing body of evidence supports the safety, efficacy, and patient outcomes associated with the da Vinci SP system. The system is also approved for use in the United States, Japan, and Korea for a range of procedures spanning multiple surgical disciplines. With over 1,000 peer-reviewed publications, the da Vinci SP system has established a strong track record of performance and patient care.

The expansion of the da Vinci SP system's applications in Europe is part of a broader strategy by Intuitive to continue innovating and improving access to minimally invasive care. The company remains focused on helping more patients access the benefits of robotic-assisted surgery, which can lead to better outcomes and improved quality of life.

In summary, the CE mark approval for the use of the da Vinci SP system in transvaginal gynecologic procedures marks a significant advancement in the technology's capabilities and accessibility in Europe. This expansion of applications is expected to benefit a wider range of patients and surgeons, potentially leading to improved recovery experiences and outcomes.